Novartis International AG, Basel (CH)
Anne Witt is Global Head Digital Business Development & Licensing. She is responsible for leading the strategic planning, transactional process, and post transaction alliance management for many of Novartis’ core strategic enterprise level partnerships. Anne is deeply committed to being a change agent and value creator at the intersection of healthcare, technology, and business. She looks forward to build on her business transformation and deal expertise in an environment with disruptive innovation potential and a corporate culture committed to cross functional collaboration and value-creating partnerships.
During her tenure at Novartis, Anne held various positions of increasing responsibilities within the global BD&L partnering team, including Chief of Staff for the Global Head of Novartis BD&L / M&A and Search & Evaluation Lead for the Cardio-Metabolic Franchise. Before joining Novartis, Anne held positions at Teva Pharmaceuticals as Associate Director for Strategic Marketing CNS and Life Technologies Corporation (now Thermo Fisher) in the Corporate M&A department. She started her career in management consulting at PricewaterhouseCoopers Corporate Finance division, focusing on advising clients in Pharma and Biotech on transactions globally.
Anne received a Master’s Degree in Science (MSc), summa cum laude, in Biochemistry and Physics from the Max Planck Institute, a Master’s of Business Administration (MBA) from Harvard University, and a Bachelor of Arts (BA) in Chemistry and Economics, summa cum laude, from Wesleyan College.